... Abbreviations: Cx, left circumflex coronary artery; LAD, left ante-rior descending coronary artery; LVEF, left ventricular ejection fraction; RCA, right coronary artery. aIndicates patients who ... J. Med. Sci. 2011, 8 http://www.medsci.org 69 (BMSs) in patients with symptomatic coronaryartery disease of simple to moderate complexity (1-3). The use of the Zotarolimus-eluting stent ... 14. Ellis SG, Vandormael MG, Cowley MJ. Coronary morphologic and clinical determinants of procedural outcome with angiop-lasty for multivessel coronary disease: implications for patient selection....
... Abbreviations: Cx, left circumflex coronary artery; LAD, left anterior descending coronary artery; LVEF, left ventricular ejection fraction; RCA, right coronary artery. aIndicates patients who ... better long-term safety and efficacy than the PES in unselected Turkish patients with coronaryartery disease. However, despite our study and several others in which the SES and the PES have ... C, Mann JT, Turco M, et al. A polymer-based, paclitaxel-eluting stent in patients with coronaryartery disease. N Engl J Med 2004;350:221-231 3. Valgimigli M, van Mieghem CA, Ong AT, Aoki J,...
... 1 Pathogenesis Coronary ArteryDisease – New Insights and Novel Approaches 283.6 Gene-gene and gene-environmental interaction in manifestation of coronaryartery disease The fact that ... influencing various aspects of coronaryartery function and structure with prevalent genetic factors. Coronary ArteryDisease – New Insights and Novel Approaches 26the disease. Plasma leptin ... surrounding network with blood supply. 2. What causes coronaryartery disease? Since coronary arteries deliver blood to the heart muscle, disease can have serious implications by reducing the...
... TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronaryartery disease: a randomised cross-over studyAndreas C Eriksson*1, Lena Jonasson2, Tomas L ... http://www.translational-medicine.com/content/7/1/42Page 7 of 14(page number not for citation purposes)Comparisons between patients with coronaryartery disease and controlsThe factors were further analysed by One-sample t-test fordifferences ... controls at two separateoccasions (Figure 2).Effects of platelet inhibiting treatment in coronaryartery disease When investigating possible effects of platelet-inhibitingtreatment with Repeated...
... [3,4].Patients with coronaryarterydisease (CAD) and refrac-tory or recurrent retrosternal symptoms have a reductionin life expectancy and HRQL compared to patients w ithstable coronaryarterydisease ... Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 2010, 363:1909-17.43. Juurlink DN: Clopidogrel with or without omeprazole in coronary disease. N Engl J Med 2011, 364:681-2.44. ... moreeffectively than the placebo.List of abbreviationsHRQL: health-related quality of life; CAD: coronaryartery disease; GER:gastroesophageal reflux; PPI: proton pump inhibitors; HRQLRAD: Quality ofLife...
... atherosclerosis. What about cardiovascular disease? The immu-nomodulatory effects of statins in various autoim-mune diseases apply equally well to cardiovascu-lar disease, in which surprisingly similar ... patients with heart fail-ure and left ventricular systolic dysfunction attri-buted to coronaryartery disease. The study, called the Controlled Rosuvastatin Multinational Trial in Heart Failure ... reconciled with the existing randomized trials of statins in patients with es-tablished coronaryartery disease? First, statins as a class may not be efficacious in patients with ischemic left...
... 56 Coronary disease on angiography 61 61Angina pectoris 70 71Percutaneous coronary intervention 42 41 Coronary- artery bypass grafting 38 40Percutaneous coronary intervention or coronary- artery ... withvascular disease who do not have overt heart failurereduces the risk of major atherosclerotic events. InHOPE, high-risk patients with vascular disease (in-cluding coronaryartery disease) or diabetes ... of Cardiac Events with Perindopril inStable CoronaryArteryDisease (EUROPA), 16 pa-tients with coronary or other vascular disease orwith diabetes and another cardiovascular risk fac-tor...
... multivessel coronaryarterydisease are CABG 100Survival (%)95908500 3 6 9 12 1518MonthsCThree-Vessel Disease A Three-Vessel Disease B Two-Vessel Disease DTwo-Vessel Disease No. at ... of diseased vessels and by the presence or absence of disease in the proximal left anterior descending (LAD) coronary artery. Data from patients with two-vessel disease who had no LAD artery ... 96.3No. of diseased vessels (%)‡ <0.0013, with proximal LAD artery 51.5 11.83, without proximal LAD artery 18.4 13.12, with proximal LAD artery 20.0 26.12, without proximal LAD artery 10.1...
... stores and the risk of coronary heart disease. N Engl J Med. 1994; 330: 1119–1124. 19. Ascherio A, Willett WC, Rimm EB, et al. Blood donations and risk of coronary heart disease in men. Circulation. ... stores, dietary iron intake and coronary heart disease mortality. J In-tern Med. 1995; 238: 223-230. 21. Liao Y, Cooper RS, McGee DL. Iron status and coronary heart disease: negative findings from ... Masironi R. Trace elements and cardiovascular diseases. Bull World Health Organ. 1969; 40: 305–312. 28. Kromhout D. Blood lead and coronary heart disease risk among elderly men in Zutphen the...